Interim Report January 1 - June 30, 2011

 | Source: RaySearch Laboratories AB RaySearch Laboratories AB 

Interim Report January 1 - June 30, 2011

JANUARY 1 - JUNE 30, 2011

  · Net sales for the period totaled SEK 47.6 M (60.9)
  · Profit after tax was SEK 1.3 M (17.4) corresponding to earnings per
share of SEK 0.04 (0.51)
  · Operating profit totaled SEK 2.0 M (23.8)
  · Cash flow was a negative SEK 27.0 M (pos: 2.1)
  · RaySearch established a sales organization in the US in January
  · Two new orders for RayStation® from Switzerland and Canada were
received in February
  · RaySearch licensed pioneering technology from Princess Margaret
Hospital in March
  · A clinic in the Netherlands placed an order for RayStation® in April
  · RaySearch became involved in a US patent dispute in May

AFTER THE END OF THE PERIOD

  · Three US cancer centers placed orders for RayStation® in August

“Financially, the first six months of the year were weak. The profit is
declining faster than the revenues due to the investment in our
proprietary RayStation® treatment planning system where costs were
incurred for development, marketing and the build-up of the sales and
service organizations, but we have not yet benefitted from significant
revenues from the product,” says Johan Löf, President of RaySearch.

“We are however starting to see results from our RayStation® sales
effort. In August, we announced three new orders from clinics in New
Jersey and New York with a combined order value exceeding one million US
dollars,” concludes Johan Löf.

FOR ADDITIONAL INFORMATION, PLEASE CONTACT:
Johan Löf, President
Tel: +46 (0)8-545 061 30
johan.lof@raysearchlabs.com (johan.lof@raysearchlabs.com)

ABOUT RaySearch
RaySearch Laboratories is a medical technology company that develops
advanced software solutions for improved radiation therapy of cancer.
RaySearch's products are mainly sold through license agreements with
leading partners such as Philips, Nucletron, IBA Dosimetry, Varian,
TomoTherapy and Siemens. To date, 15 products have been launched through
partners and RaySearch's software is used at some 1,800 clinics in more
than 30 countries. In addition, RaySearch offers the proprietary
treatment planning system RayStation® directly to clinics. RaySearch was
founded in 2000 as a spin-off from Karolinska Institutet in Stockholm
and the company is listed in the Small Cap segment on NASDAQ OMX
Stockholm.

For more information about RaySearch, visit
www.raysearchlabs.com (http://www.raysearchlabs.com/).

Pièces jointes